Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
7 studies found for:    "antithrombin deficiency"
Show Display Options
Rank Status Study
1 Completed A Study of KW-3357 in Congenital Antithrombin Deficiency
Condition: Congenital Antithrombin Deficiency
Intervention: Drug: KW-3357
2 Completed
Has Results
Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery
Condition: Antithrombin III Deficiency
Intervention: Biological: Recombinant human antithrombin (rhAT)
3 Completed
Has Results
Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations.
Condition: Antithrombin Deficiency, Congenital
Intervention: Biological: Recombinant Human Antithrombin (rhAT)
4 Recruiting Safety, Pharmacokinetics and Efficacy of an AT-III Concentrate.
Condition: Antithrombin III Deficiency
Intervention: Drug: Plasma-derived AT-III concentrate
5 Not yet recruiting Atenativ Effect on Uterine Blood Flow and Preeclampsia
Condition: Antithrombin III Deficiency
Intervention: Drug: Atenativ
6 Completed Use of Antithrombin in Cardiac Surgery With Cardiopulmonary Bypass
Conditions: Acquired Antithrombin III Deficiency;   Coronary Artery Bypass
Intervention: Drug: Antithrombin III
7 Recruiting Anti-thrombin III (ATIII) vs Placebo in Children (<6mo) Undergoing Open Congenital Cardiac Surgery
Condition: ATIII Deficiency
Interventions: Drug: Anti-thrombin III;   Other: Placebo

Indicates status has not been verified in more than two years